- Home
- SNDX vs NGVT Comparison
SNDX vs NGVT Comparison
Compare SNDX & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- NGVT
- Stock Information
- Founded
- SNDX 2005
- NGVT 1964
- Country
- SNDX United States
- NGVT United States
- Employees
- SNDX N/A
- NGVT N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- NGVT Major Chemicals
- Sector
- SNDX Health Care
- NGVT Industrials
- Exchange
- SNDX Nasdaq
- NGVT Nasdaq
- Market Cap
- SNDX 1.6B
- NGVT 1.5B
- IPO Year
- SNDX 2016
- NGVT N/A
- Fundamental
- Price
- SNDX $15.83
- NGVT $45.96
- Analyst Decision
- SNDX Strong Buy
- NGVT Buy
- Analyst Count
- SNDX 11
- NGVT 5
- Target Price
- SNDX $36.00
- NGVT $51.00
- AVG Volume (30 Days)
- SNDX 1.7M
- NGVT 404.8K
- Earning Date
- SNDX 11-05-2024
- NGVT 10-29-2024
- Dividend Yield
- SNDX N/A
- NGVT N/A
- EPS Growth
- SNDX N/A
- NGVT N/A
- EPS
- SNDX N/A
- NGVT N/A
- Revenue
- SNDX $16,000,000.00
- NGVT $1,479,300,000.00
- Revenue This Year
- SNDX N/A
- NGVT N/A
- Revenue Next Year
- SNDX $219.92
- NGVT $2.64
- P/E Ratio
- SNDX N/A
- NGVT N/A
- Revenue Growth
- SNDX N/A
- NGVT N/A
- 52 Week Low
- SNDX $14.81
- NGVT $30.90
- 52 Week High
- SNDX $25.34
- NGVT $56.30
- Technical
- Relative Strength Index (RSI)
- SNDX 32.96
- NGVT 64.55
- Support Level
- SNDX $16.03
- NGVT $44.62
- Resistance Level
- SNDX $17.87
- NGVT $47.95
- Average True Range (ATR)
- SNDX 0.93
- NGVT 1.96
- MACD
- SNDX -0.45
- NGVT 0.45
- Stochastic Oscillator
- SNDX 1.26
- NGVT 81.75
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About NGVT Ingevity Corporation
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.